Loading…
Reduction in Pancreatic Transcription Factor PDX-1 Impairs Glucose-stimulated Insulin Secretion
Complete lack of transcription factor PDX-1 leads to pancreatic agenesis, whereas heterozygosity for PDX-1 mutations has been recently noted in some individuals with maturity-onset diabetes of the young (MODY) and in some individuals with type 2 diabetes. To determine how alterations in PDX-1 affect...
Saved in:
Published in: | The Journal of biological chemistry 2002-03, Vol.277 (13), p.11225-11232 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c506t-ec400b8d2fbbed5c182ac0a8217ba2793a418d3ad3bfed90963553f52e7395193 |
---|---|
cites | cdi_FETCH-LOGICAL-c506t-ec400b8d2fbbed5c182ac0a8217ba2793a418d3ad3bfed90963553f52e7395193 |
container_end_page | 11232 |
container_issue | 13 |
container_start_page | 11225 |
container_title | The Journal of biological chemistry |
container_volume | 277 |
creator | Brissova, Marcela Shiota, Masakazu Nicholson, Wendell E. Gannon, Maureen Knobel, Susan M. Piston, David W. Wright, Christopher V.E. Powers, Alvin C. |
description | Complete lack of transcription factor PDX-1 leads to pancreatic agenesis, whereas heterozygosity for PDX-1 mutations has been recently noted in some individuals with maturity-onset diabetes of the young (MODY) and in some individuals with type 2 diabetes. To determine how alterations in PDX-1 affect islet function, we examined insulin secretion and islet physiology in mice with one PDX-1 allele inactivated. PDX-1+/− mice had a normal fasting blood glucose and pancreatic insulin content but had impaired glucose tolerance and secreted less insulin during glucose tolerance testing. The expression of PDX-1 and glucose transporter 2 in islets from PDX-1+/−mice was reduced to 68 and 55%, respectively, whereas glucokinase expression was not significantly altered. NAD(P)H generation in response to glucose was reduced by 30% in PDX-1+/− mice. The in situ perfused pancreas of PDX-1+/− mice secreted about 45% less insulin when stimulated with 16.7 mm glucose. The Km for insulin release was similar in wild type and PDX-1+/− mice. Insulin secretion in response to 20 mm arginine was unchanged; the response to 10 nm glucagon-like peptide-1 was slightly increased. However, insulin secretory responses to 10 mm 2-ketoisocaproate and 20 mm KCl were significantly reduced (by 61 and 66%, respectively). These results indicate that a modest reduction in PDX-1 impairs several events in glucose-stimulated insulin secretion (such as NAD(P)H generation, mitochondrial function, and/or mobilization of intracellular Ca2+) and that PDX-1 is important for normal function of adult pancreatic islets. |
doi_str_mv | 10.1074/jbc.M111272200 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71547227</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925818521463</els_id><sourcerecordid>71547227</sourcerecordid><originalsourceid>FETCH-LOGICAL-c506t-ec400b8d2fbbed5c182ac0a8217ba2793a418d3ad3bfed90963553f52e7395193</originalsourceid><addsrcrecordid>eNqFkD1PHDEQhq0oKFwgbUq0RUS3h8de43WJSICTQEGBSHSWdzybM9qPi71LlH8fw51EFeFmCj_vO6OHsc_Al8B1dfLY4PIGAIQWgvN3bAG8lqVU8PCeLTgXUBqh6n32MaVHnl9l4APbB9A1SCEXzP4gP-MUxqEIQ3HrBozkpoDFfXRDwhg2L38XDqcxFrdfH0ooVv3GhZiKy27GMVGZptDPnZvIF6shzV0uuqPc85w8ZHut6xJ92s0D9vPi2_35VXn9_XJ1fnZdouKnU0lYcd7UXrRNQ14h1MIhd7UA3TihjXQV1F46L5uWvOHmVColWyVIS6PAyAN2vO3dxPH3TGmyfUhIXecGGudkNagqK9Jvgnmz4dpUGVxuQYxjSpFau4mhd_GvBW6f3dvs3r66z4GjXfPc9ORf8Z3sDHzZAuvwa_0nRLJNGHFNvRVaW5CZFEJlrN5ilH09BYo2YaAByecITtaP4X8n_ANMEJ47</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18290794</pqid></control><display><type>article</type><title>Reduction in Pancreatic Transcription Factor PDX-1 Impairs Glucose-stimulated Insulin Secretion</title><source>ScienceDirect Journals</source><creator>Brissova, Marcela ; Shiota, Masakazu ; Nicholson, Wendell E. ; Gannon, Maureen ; Knobel, Susan M. ; Piston, David W. ; Wright, Christopher V.E. ; Powers, Alvin C.</creator><creatorcontrib>Brissova, Marcela ; Shiota, Masakazu ; Nicholson, Wendell E. ; Gannon, Maureen ; Knobel, Susan M. ; Piston, David W. ; Wright, Christopher V.E. ; Powers, Alvin C.</creatorcontrib><description>Complete lack of transcription factor PDX-1 leads to pancreatic agenesis, whereas heterozygosity for PDX-1 mutations has been recently noted in some individuals with maturity-onset diabetes of the young (MODY) and in some individuals with type 2 diabetes. To determine how alterations in PDX-1 affect islet function, we examined insulin secretion and islet physiology in mice with one PDX-1 allele inactivated. PDX-1+/− mice had a normal fasting blood glucose and pancreatic insulin content but had impaired glucose tolerance and secreted less insulin during glucose tolerance testing. The expression of PDX-1 and glucose transporter 2 in islets from PDX-1+/−mice was reduced to 68 and 55%, respectively, whereas glucokinase expression was not significantly altered. NAD(P)H generation in response to glucose was reduced by 30% in PDX-1+/− mice. The in situ perfused pancreas of PDX-1+/− mice secreted about 45% less insulin when stimulated with 16.7 mm glucose. The Km for insulin release was similar in wild type and PDX-1+/− mice. Insulin secretion in response to 20 mm arginine was unchanged; the response to 10 nm glucagon-like peptide-1 was slightly increased. However, insulin secretory responses to 10 mm 2-ketoisocaproate and 20 mm KCl were significantly reduced (by 61 and 66%, respectively). These results indicate that a modest reduction in PDX-1 impairs several events in glucose-stimulated insulin secretion (such as NAD(P)H generation, mitochondrial function, and/or mobilization of intracellular Ca2+) and that PDX-1 is important for normal function of adult pancreatic islets.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.M111272200</identifier><identifier>PMID: 11781323</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Female ; glucagon-like peptide 1 ; Glucose - pharmacology ; glucose transporter 2 ; Heterozygote ; Homeodomain Proteins ; Immunohistochemistry ; Insulin - blood ; Insulin - metabolism ; Insulin Secretion ; Islets of Langerhans - drug effects ; Islets of Langerhans - metabolism ; Male ; Mice ; Mice, Knockout ; NADPH ; PDX-1 protein ; Trans-Activators - genetics ; Trans-Activators - metabolism ; Trans-Activators - physiology</subject><ispartof>The Journal of biological chemistry, 2002-03, Vol.277 (13), p.11225-11232</ispartof><rights>2002 © 2002 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c506t-ec400b8d2fbbed5c182ac0a8217ba2793a418d3ad3bfed90963553f52e7395193</citedby><cites>FETCH-LOGICAL-c506t-ec400b8d2fbbed5c182ac0a8217ba2793a418d3ad3bfed90963553f52e7395193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0021925818521463$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11781323$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brissova, Marcela</creatorcontrib><creatorcontrib>Shiota, Masakazu</creatorcontrib><creatorcontrib>Nicholson, Wendell E.</creatorcontrib><creatorcontrib>Gannon, Maureen</creatorcontrib><creatorcontrib>Knobel, Susan M.</creatorcontrib><creatorcontrib>Piston, David W.</creatorcontrib><creatorcontrib>Wright, Christopher V.E.</creatorcontrib><creatorcontrib>Powers, Alvin C.</creatorcontrib><title>Reduction in Pancreatic Transcription Factor PDX-1 Impairs Glucose-stimulated Insulin Secretion</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>Complete lack of transcription factor PDX-1 leads to pancreatic agenesis, whereas heterozygosity for PDX-1 mutations has been recently noted in some individuals with maturity-onset diabetes of the young (MODY) and in some individuals with type 2 diabetes. To determine how alterations in PDX-1 affect islet function, we examined insulin secretion and islet physiology in mice with one PDX-1 allele inactivated. PDX-1+/− mice had a normal fasting blood glucose and pancreatic insulin content but had impaired glucose tolerance and secreted less insulin during glucose tolerance testing. The expression of PDX-1 and glucose transporter 2 in islets from PDX-1+/−mice was reduced to 68 and 55%, respectively, whereas glucokinase expression was not significantly altered. NAD(P)H generation in response to glucose was reduced by 30% in PDX-1+/− mice. The in situ perfused pancreas of PDX-1+/− mice secreted about 45% less insulin when stimulated with 16.7 mm glucose. The Km for insulin release was similar in wild type and PDX-1+/− mice. Insulin secretion in response to 20 mm arginine was unchanged; the response to 10 nm glucagon-like peptide-1 was slightly increased. However, insulin secretory responses to 10 mm 2-ketoisocaproate and 20 mm KCl were significantly reduced (by 61 and 66%, respectively). These results indicate that a modest reduction in PDX-1 impairs several events in glucose-stimulated insulin secretion (such as NAD(P)H generation, mitochondrial function, and/or mobilization of intracellular Ca2+) and that PDX-1 is important for normal function of adult pancreatic islets.</description><subject>Animals</subject><subject>Female</subject><subject>glucagon-like peptide 1</subject><subject>Glucose - pharmacology</subject><subject>glucose transporter 2</subject><subject>Heterozygote</subject><subject>Homeodomain Proteins</subject><subject>Immunohistochemistry</subject><subject>Insulin - blood</subject><subject>Insulin - metabolism</subject><subject>Insulin Secretion</subject><subject>Islets of Langerhans - drug effects</subject><subject>Islets of Langerhans - metabolism</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>NADPH</subject><subject>PDX-1 protein</subject><subject>Trans-Activators - genetics</subject><subject>Trans-Activators - metabolism</subject><subject>Trans-Activators - physiology</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNqFkD1PHDEQhq0oKFwgbUq0RUS3h8de43WJSICTQEGBSHSWdzybM9qPi71LlH8fw51EFeFmCj_vO6OHsc_Al8B1dfLY4PIGAIQWgvN3bAG8lqVU8PCeLTgXUBqh6n32MaVHnl9l4APbB9A1SCEXzP4gP-MUxqEIQ3HrBozkpoDFfXRDwhg2L38XDqcxFrdfH0ooVv3GhZiKy27GMVGZptDPnZvIF6shzV0uuqPc85w8ZHut6xJ92s0D9vPi2_35VXn9_XJ1fnZdouKnU0lYcd7UXrRNQ14h1MIhd7UA3TihjXQV1F46L5uWvOHmVColWyVIS6PAyAN2vO3dxPH3TGmyfUhIXecGGudkNagqK9Jvgnmz4dpUGVxuQYxjSpFau4mhd_GvBW6f3dvs3r66z4GjXfPc9ORf8Z3sDHzZAuvwa_0nRLJNGHFNvRVaW5CZFEJlrN5ilH09BYo2YaAByecITtaP4X8n_ANMEJ47</recordid><startdate>20020329</startdate><enddate>20020329</enddate><creator>Brissova, Marcela</creator><creator>Shiota, Masakazu</creator><creator>Nicholson, Wendell E.</creator><creator>Gannon, Maureen</creator><creator>Knobel, Susan M.</creator><creator>Piston, David W.</creator><creator>Wright, Christopher V.E.</creator><creator>Powers, Alvin C.</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>7X8</scope></search><sort><creationdate>20020329</creationdate><title>Reduction in Pancreatic Transcription Factor PDX-1 Impairs Glucose-stimulated Insulin Secretion</title><author>Brissova, Marcela ; Shiota, Masakazu ; Nicholson, Wendell E. ; Gannon, Maureen ; Knobel, Susan M. ; Piston, David W. ; Wright, Christopher V.E. ; Powers, Alvin C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c506t-ec400b8d2fbbed5c182ac0a8217ba2793a418d3ad3bfed90963553f52e7395193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Female</topic><topic>glucagon-like peptide 1</topic><topic>Glucose - pharmacology</topic><topic>glucose transporter 2</topic><topic>Heterozygote</topic><topic>Homeodomain Proteins</topic><topic>Immunohistochemistry</topic><topic>Insulin - blood</topic><topic>Insulin - metabolism</topic><topic>Insulin Secretion</topic><topic>Islets of Langerhans - drug effects</topic><topic>Islets of Langerhans - metabolism</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>NADPH</topic><topic>PDX-1 protein</topic><topic>Trans-Activators - genetics</topic><topic>Trans-Activators - metabolism</topic><topic>Trans-Activators - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brissova, Marcela</creatorcontrib><creatorcontrib>Shiota, Masakazu</creatorcontrib><creatorcontrib>Nicholson, Wendell E.</creatorcontrib><creatorcontrib>Gannon, Maureen</creatorcontrib><creatorcontrib>Knobel, Susan M.</creatorcontrib><creatorcontrib>Piston, David W.</creatorcontrib><creatorcontrib>Wright, Christopher V.E.</creatorcontrib><creatorcontrib>Powers, Alvin C.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brissova, Marcela</au><au>Shiota, Masakazu</au><au>Nicholson, Wendell E.</au><au>Gannon, Maureen</au><au>Knobel, Susan M.</au><au>Piston, David W.</au><au>Wright, Christopher V.E.</au><au>Powers, Alvin C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduction in Pancreatic Transcription Factor PDX-1 Impairs Glucose-stimulated Insulin Secretion</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2002-03-29</date><risdate>2002</risdate><volume>277</volume><issue>13</issue><spage>11225</spage><epage>11232</epage><pages>11225-11232</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>Complete lack of transcription factor PDX-1 leads to pancreatic agenesis, whereas heterozygosity for PDX-1 mutations has been recently noted in some individuals with maturity-onset diabetes of the young (MODY) and in some individuals with type 2 diabetes. To determine how alterations in PDX-1 affect islet function, we examined insulin secretion and islet physiology in mice with one PDX-1 allele inactivated. PDX-1+/− mice had a normal fasting blood glucose and pancreatic insulin content but had impaired glucose tolerance and secreted less insulin during glucose tolerance testing. The expression of PDX-1 and glucose transporter 2 in islets from PDX-1+/−mice was reduced to 68 and 55%, respectively, whereas glucokinase expression was not significantly altered. NAD(P)H generation in response to glucose was reduced by 30% in PDX-1+/− mice. The in situ perfused pancreas of PDX-1+/− mice secreted about 45% less insulin when stimulated with 16.7 mm glucose. The Km for insulin release was similar in wild type and PDX-1+/− mice. Insulin secretion in response to 20 mm arginine was unchanged; the response to 10 nm glucagon-like peptide-1 was slightly increased. However, insulin secretory responses to 10 mm 2-ketoisocaproate and 20 mm KCl were significantly reduced (by 61 and 66%, respectively). These results indicate that a modest reduction in PDX-1 impairs several events in glucose-stimulated insulin secretion (such as NAD(P)H generation, mitochondrial function, and/or mobilization of intracellular Ca2+) and that PDX-1 is important for normal function of adult pancreatic islets.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>11781323</pmid><doi>10.1074/jbc.M111272200</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9258 |
ispartof | The Journal of biological chemistry, 2002-03, Vol.277 (13), p.11225-11232 |
issn | 0021-9258 1083-351X |
language | eng |
recordid | cdi_proquest_miscellaneous_71547227 |
source | ScienceDirect Journals |
subjects | Animals Female glucagon-like peptide 1 Glucose - pharmacology glucose transporter 2 Heterozygote Homeodomain Proteins Immunohistochemistry Insulin - blood Insulin - metabolism Insulin Secretion Islets of Langerhans - drug effects Islets of Langerhans - metabolism Male Mice Mice, Knockout NADPH PDX-1 protein Trans-Activators - genetics Trans-Activators - metabolism Trans-Activators - physiology |
title | Reduction in Pancreatic Transcription Factor PDX-1 Impairs Glucose-stimulated Insulin Secretion |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T07%3A21%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduction%20in%20Pancreatic%20Transcription%20Factor%20PDX-1%20Impairs%20Glucose-stimulated%20Insulin%20Secretion&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Brissova,%20Marcela&rft.date=2002-03-29&rft.volume=277&rft.issue=13&rft.spage=11225&rft.epage=11232&rft.pages=11225-11232&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.M111272200&rft_dat=%3Cproquest_cross%3E71547227%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c506t-ec400b8d2fbbed5c182ac0a8217ba2793a418d3ad3bfed90963553f52e7395193%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=18290794&rft_id=info:pmid/11781323&rfr_iscdi=true |